GIS
31
3
WM
79
3
A
43
2
EQIX
64
2
LLY
37
-3
ZION
65
2
NSC
60
3
SE
61
-4
PPL
54
-5
SYK
64
-4
CA
38
6
PVH
62
5
CFG
70
6
INTU
56
-4
HPE
63
2
BWA
48
2
PBI
69
4
STZ
54
-3
AIV
72
2
CAH
48
-5
GIS
31
3
WM
79
3
A
43
2
EQIX
64
2
LLY
37
-3
ZION
65
2
NSC
60
3
SE
61
-4
PPL
54
-5
SYK
64
-4
CA
38
6
PVH
62
5
CFG
70
6
INTU
56
-4
HPE
63
2
BWA
48
2
PBI
69
4
STZ
54
-3
AIV
72
2
CAH
48
-5
Financhill
Back

Checkpoint Therapeutics 10K Form

Sell
46

CKPT
Checkpoint Therapeutics

Last Price:
3.74
Seasonality Move:
10.23%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CKPT News And Ratings

See the #1 stock for the next 7 days that we like better than CKPT

CKPT Financial Statistics

Sales & Book Value

Annual Sales: $103K
Cash Flow: $-11.21M
Price / Cash Flow: 0
Annual Sales: $-0.27
Price / Book: 0

Profitability

EPS (TTM): -1.84000
Net Income (TTM): $-46.47M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Checkpoint Therapeutics Earnings Forecast

Key Checkpoint Therapeutics Financial Ratios

  • The Research & Development expenses have been 42,297.09% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of CKPT is -50,336.89% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 5 years.

Checkpoint Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CKPT
CUSIP: 162828
Website: checkpointtx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CKPT Technical Analysis vs Fundamental Analysis

Sell
46
Checkpoint Therapeutics (CKPT) is a Sell

Is Checkpoint Therapeutics a Buy or a Sell?